日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Industries

Pharma association issues report on innovative drugs

By Liu Zhihua | chinadaily.com.cn | Updated: 2021-04-21 17:44
Share
Share - WeChat
The Executive Committee of the Research & Development-based Pharmaceutical Association Committee under the China Association of Enterprises with Foreign Investment held an event on Tuesday to release a report on the innovative pharmaceutical industry and its role in the implementation of the Healthy China 2030 initiative. [Photo provided to chinadaily.com.cn]

A total of 200 innovative drugs have been approved in China over the past five years, among which many have been included in public-funded medical insurance programs, according to a recent report by the Executive Committee of the Research & Development-based Pharmaceutical Association Committee under the China Association of Enterprises with Foreign Investment.

Focusing on the innovative pharmaceutical industry and its role in the implementation of the Healthy China 2030 initiative, the report said about 33 percent of innovative drugs approved in the past five years are tumor treatments, and about 80 percent of the drugs, or 156 titles, are from multinational pharmaceutical companies.

The innovative drugs registered by multinational pharmaceutical companies have also showed more diversity in the past five years, as the share of tumor treatments has dropped to 33 percent from 47 percent in the period from 2010 to 2015, while more drugs for diseases related to the nervous system, digestion and the cardiovascular and respiratory systems have been registered.

Yang Ying, vice-president of Worldwide Business Development Asia at US-based pharmaceutical company Pfizer, said foreign pharmaceutical enterprises see China not only as an important market, but also an important investment destination for both commercialization and research and development.

As Chinese enterprises show increasing innovation capabilities, there are more cooperation opportunities for foreign and domestic enterprises in pharmaceutical industry, she said.

However, high costs and patients' lack of access to innovative drugs still remain a problem for the innovative pharmaceutical industry in China, according to the report.

Innovative drugs only account for about 9 percent of the total pharmaceutical market in China, the world's second-largest pharmaceutical market in the world, while in other G20 member countries the figure is all above 20 percent, and in developed countries such as the United States, Japan and Germany, the figure is more than 50 percent.

Kang Wei, managing director of RDPAC, suggested promoting the development of commercial insurance to increase the accessibility of innovative drugs and thus better meet Chinese patients' clinical demands.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 五月婷婷丁香在线观看 | 久久女人被添全过程A片 | 久操不卡 | 久久精品视频大全 | 欧美成年黄网站色视频 | xx00视频 | 婷婷综合激情五月中文字幕 | 久久无码AV亚洲精品色午夜 | 91精品国产色综合久久 | 27xxoo无遮挡动态视频 | 欧美性xxxx交 | 免费观看黄色小视频 | 日韩一区免费在线观看 | 精品黑人一区二区三区 | 久久久综合网 | 欧美日韩亚洲综合另类ac | 国产精品污污视频 | 亚洲码欧美码一区二区三区 | 国产精品一卡二卡三卡 | 精品一区二区久久久久久久网站 | 丁香婷婷综合五月六月 | 国产精品亚洲国产 | 51国产午夜精品免费视频 | 色客成人网 | 日本人麻豆 | 日韩a级片 | 久草手机在线播放 | 成人亚洲国产精品久久 | 色视频在线免费观看 | 加勒比欧美 | 日韩欧美一区二区三区 | 九色av| 特黄aaaaa日本大片免费看 | avtt天堂网Av无码 | 久久中文字幕在线 | 亚洲天堂视频在线观看免费 | 亚洲成人免费在线 | 视频三区| 91久久国产口精品久久久久 | 久久最新精品 | 久久人人爽人人爽人人片va |